IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Incannex to Acquire APIRx Pharmaceuticals, page-37

  1. 1 Posts.
    lightbulb Created with Sketch. 1
    Most impressive IP’s on their list IMO
    All the skin conditions: psoriasis, dermatitis, vitiligo
    None of these have cures and current management is basically steroid creams which you don’t want to use long term due to side effects

    Glaucoma - leading cause of blindness worldwide. Currently no cure

    Suppositories - excellent delivery method for more efficacy in our products for inflammatory bowel disease

    then there is this curious “flotex-C” sustained release capsule for unmet needs - screams IHL

    Huge boost to the product range of this gem of a company.
    Did we need it? No
    Do we like it? Absolutely

    DYOR
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.